Holen Sie sich die Stockscreener-App
97.39
1.22%
-1.275
Biontech Se Adr Aktie (BNTX) Neueste Nachrichten
Pfizer Stock Rises Almost 9% in 3 Months: Time to Buy, Hold or Exit? - TradingView
BNTX Stock Quote Price and Forecast - CNN
BioNTech CEO Ugur Sahin Executes Sale of 76,500 Shares Under Rule 10b5-1 Plan - Kalkine Media
Why Pfizer Stock Was so Healthy in August - The Motley Fool
This Best Buy Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Tuesday - Benzinga
Robinhood To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
Why is BioNTech stock sliding today? - Investing.com
BioNTech's Promising Oncology Pipeline Is Now in Late-Stage Development - Morningstar
PTC Therapeutics (PTCT) Moves 7.2% Higher: Will This Strength Last? - Eastern Progress
BioNTech's September Test: Can Oncology Data Outweigh a Shrinking COVID Franchise? () - aktiencheck.de
BioNTech SEADR (BNTX) Fundamental & Financial Data - Stocktwits
BioNTech's Seoul Moment: Why One Halted Trial Hasn't Derailed the Oncology Narrative () - aktiencheck.de
BioNTech's September Crossroads: Seoul Data Readouts and Factory Decisions Will Test the Post-Trial Narrative - aktiencheck.de
BioNTech's Two-Front Battle: Legal Overhang in Europe Meets a Pivotal September for Oncology Data - aktiencheck.de
BNTX stock reacts to halted cancer trial and lower 2026 guidance - AD HOC NEWS
Zacks Investment ResearchGlobes - Globes - Israel Business News
BNTX Ends Colorectal Cancer Immunotherapy Study, Stock Down - Eastern Progress
BioNTech's Leadership Exodus Looms as Vaccine Franchise Holds While Oncology Ambitions Take a Hit - aktiencheck.de
BioNTech's Split-Screen Week: A Trial Halted, a Vaccine Approved, and a Pipeline Under the Microscope - aktiencheck.de
Why is BioNTech stock down 7.8% today? - Traders Union
BioNTech stock tumbles 10% on cancer trial termination - Investing.com
Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine - Barchart.com
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
FDA approves Pfizer-BioNTech COVID vaccine targeting XFG variant - Investing.com
global market • stocks • Vienna Stock Exchange - wienerborse.at
Should You Buy Moderna Stock Following Its Cancer Breakthrough? - TradingView
BioNTech Moved Higher as the Broader Biotech Sector Hit a Post-Pandemic Peak, but BNTX Stock Needs Stronger Fundamentals to Keep Climbing - Barchart.com
Market Wrap: Stocks Fall as Industrials and Utilities Decline - Morningstar
BioNTech’s New HIV RNA Vaccine Trial: What Investors Should Watch Now - TipRanks
BioNTech jumps $5.1 billion in premarket; analyst target now just 8% higher - TechStock²
Merck Raises the Stakes for Pfizer's Cancer Vaccine AmbitionsModerna (NASDAQ:MRNA), Merck & Co (NYSE:M - Benzinga
Is Cancer the Next Breakthrough for Moderna After COVID-19? - TradingView
Moderna ascends more than 175% from cancer vaccine breakthrough - Mugglehead Investment Magazine
BioNTech Highlights Late-Stage Lung Cancer Pipeline Momentum and First Global Data for Pumitamig/Elfetabart Drozuntecan Novel-Novel Combination at WCLC 2026 - Barchart.com
BioNTech SE Stock Jumps As Traders Bet On Post-COVID Pivot - StocksToTrade
European ADRs Rose In US Trading, Led By BioNTech - Finimize
Let's uncover which stocks are experiencing notable gaps during today's session. - ChartMill
Estee Lauder, Moderna, Merck And Other Big Stocks Moving Higher On Wednesday - Benzinga
BioNTech Up Over 21%, On Track for Largest Percent Increase Since May 2020 -- Data Talk - Moomoo
BioNTech’s rally on Moderna trial win likely to fade, Leerink says - Seeking Alpha
U.S. Listings For German Scale-ups | Part 2 - orrick.com
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
BIONTECH SE BIONTECH SE ADR (0A3M.L) Q1 FY2026 earnings call transcript - Yahoo Finance
BioNTech SE (BNTX) stock price, news, quote and history - Yahoo Finance Australia
BioNTech (BNTX) Short Interest & Short Float | Updated Aug 2026 - MarketBeat
Pfizer Rises Almost 7% Post Q2 Results: How to Play the Stock - TradingView
Bank of America Corp DE Raises Stake in BioNTech SE Sponsored ADR $BNTX - MarketBeat
BioNTech's Double Whammy: A CEO Transition Lands in the Middle of a Guidance Cut () - aktiencheck.de
Assenagon Asset Management S.A. Makes New $39.38 Million Investment in BioNTech SE Sponsored ADR $BNTX - MarketBeat
BioNTech's Second Quarter Puts a Founder's Exit and a Shrinking COVID Franchise in Sharp Relief - aktiencheck.de
Bank of New York Mellon Corp Trims Stock Position in BioNTech SE Sponsored ADR $BNTX - MarketBeat
Pfizer and BioNTech Advance Next‑Season Pediatric COVID‑19 Booster Strategy With New Phase 3 Update - TipRanks
Pfizer and BioNTech Advance Variant-Adapted COVID-19 Booster in New Phase 4 Study - tipranks.com
BioNTech SE Sponsored ADR Revenue Breakdown – BSESOF:22UA - TradingView
Caution with BioNTech! Novo Nordisk Accelerates! Buying Opportunity in Vidac Pharma Stock? - news.financial
Pfizer and BioNTech Lock In Next-Gen Pediatric COVID Booster Edge - TipRanks
BioNTech Earnings Call: COVID Slide, Oncology Push - tipranks.com
BioNTech SE (BNTX) Stock Forecasts - Yahoo Finance
0.63%
3.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):